home / stock / trda / trda quote
Last: | $17.11 |
---|---|
Change Percent: | -0.82% |
Open: | $17.12 |
Close: | $17.11 |
High: | $17.27 |
Low: | $16.7295 |
Volume: | 86,929 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$17.11 | $17.12 | $17.11 | $17.27 | $16.7295 | 86,929 | 07-22-2024 |
$16.98 | $16.98 | $16.98 | $17.18 | $16.685 | 68,466 | 07-19-2024 |
$16.88 | $17.06 | $16.88 | $17.665 | $16.67 | 136,628 | 07-18-2024 |
$17.12 | $17.51 | $17.12 | $17.76 | $16.74 | 99,015 | 07-17-2024 |
$17.76 | $18.17 | $17.76 | $18.17 | $17.48 | 120,689 | 07-16-2024 |
$17.86 | $17.36 | $17.86 | $18 | $17.18 | 168,520 | 07-15-2024 |
$17.15 | $17.8 | $17.15 | $18 | $16.72 | 190,486 | 07-12-2024 |
$17.37 | $15.99 | $17.37 | $17.58 | $15.82 | 243,378 | 07-11-2024 |
$15.74 | $15.6 | $15.74 | $16 | $15.33 | 154,815 | 07-10-2024 |
$15.56 | $15.31 | $15.56 | $15.9 | $15.15 | 122,369 | 07-09-2024 |
$15.15 | $14.27 | $15.15 | $15.2 | $13.96 | 82,133 | 07-08-2024 |
$14.13 | $14.02 | $14.13 | $14.21 | $13.78 | 92,661 | 07-05-2024 |
$14.19 | $13.99 | $14.19 | $14.26 | $13.86 | 30,842 | 07-04-2024 |
$14.19 | $13.99 | $14.19 | $14.26 | $13.86 | 30,842 | 07-03-2024 |
$14 | $14.36 | $14 | $14.525 | $13.98 | 59,559 | 07-02-2024 |
$14.32 | $14.41 | $14.32 | $14.5 | $13.95 | 84,898 | 07-01-2024 |
$14.25 | $14.34 | $14.25 | $14.515 | $13.98 | 742,761 | 06-28-2024 |
$14.17 | $14.32 | $14.17 | $14.44 | $13.98 | 56,943 | 06-27-2024 |
$14.1 | $14.54 | $14.1 | $14.61 | $13.99 | 104,170 | 06-26-2024 |
$14.77 | $14.15 | $14.77 | $15.06 | $14.15 | 132,525 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Entrada Therapeutics Inc. Company Name:
TRDA Stock Symbol:
NASDAQ Market:
Entrada Therapeutics Inc. Website:
2024-06-25 08:00:07 ET Raghuram Selvaraju from H.C. Wainwright issued a price target of $18.00 for TRDA on 2024-06-25 06:24:00. The adjusted price target was set to $18.00. At the time of the announcement, TRDA was trading at $14.24. TRDA currently trades -33.80% versus ...
BOSTON, June 24, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. The Company today an...
– ENTR-601-44 was well-tolerated in healthy volunteers with no serious adverse events, no drug-related adverse events and no clinically significant changes or trends noted in vital signs, ECGs, physical exams or laboratory assessments – – ENTR-601-44 demonstrat...